BioLegend Competitors and Similar CompaniesClear all

BioLegend's competitors and similar companies include Santa Cruz Biotechnology, Merck and Abcam.

	BioLegend BioLegend is a company that develops and manufactures antibodies and reagents.	Santa Cruz Biotechnology Santa Cruz Biotechnology (SCBT) is a company engaged in the development of products for the biomedical research market.	Merck Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.	Abcam Abcam is a life sciences company that identifies and develops biological, protein, and custom cell engineering tools.
Founding Date	Founding Date 2002	Founding Date 1991	Founding Date 1891	Founding Date 1998
Type	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development life sciences	Tags Healthcare biotech chemicals clinical research	Tags Healthcare biotech diabetes distribution drug development oncology pharma therapy	Tags Healthcare biotech life sciences
Locations	Locations San Diego, US HQ Beijing, CN Tokyo, JP	Locations Dallas, US HQ Shanghai, CN Heidelberg, DE Paso Robles, US Santa Cruz, US Sun Valley, US	Locations Rahway, US HQ Hydra, DZ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE see more	Locations HQ Hangzhou Shi, CN Shanghai, CN Hong Kong, HK Tokyo, JP Branford, US Burlingame, US see more
Employees	Employees 6781% increase	Employees 1701% increase	Employees 72,0007% increase	Employees 1,49229% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $60.1b (FY, 2023)	Revenue (est.) £361.7m (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $16.1b (FY, 2023)	Cost of goods £37.3m (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $44b (FY, 2023)	Gross profit £324.4m (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income $377m (FY, 2023)	Net income (£8.5m) (FY, 2022)